| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ridaforolimus | serine/threonine-protein kinase mtor | small molecule | Successful target | TTD , drugbank , DGIDB | Neoplasms[MeSHID:D009369] Sarcoma[MeSHID:D012509] Malignant neoplasm of prostate[MeSHID:D011471] Neoplasm Metastasis[MeSHID:D009362] Endometrial Carcinoma[MeSHID:D016889] Bone Tissue[MeSHID:D001842] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.13 | investigational,phase 3 | inhibitor |
| ridaforolimus | serine/threonine-protein kinase mtor | small molecule | Successful target | TTD , drugbank , DGIDB | Neoplasms[MeSHID:D009369] Sarcoma[MeSHID:D012509] Malignant neoplasm of prostate[MeSHID:D011471] Neoplasm Metastasis[MeSHID:D009362] Endometrial Carcinoma[MeSHID:D016889] Bone Tissue[MeSHID:D001842] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.13 | investigational,phase 3 | unknown |
| click here to return to the previous page | ||||||||